IVF INVO Fertility, Inc.

BEARISH Impact: 6/10 PRESS-RELEASE
Horizon weeks Filed Jun 2, 2026 Processed 2d 23h ago Wire GlobeNewswire
Press release: activist

Price Chart

Loading chart...

Executive Summary

INVO Fertility disclosed a Nasdaq delinquency notice for late filing of its 10-K (FY2025) and 10-Q (Q1 2026). The 10-K was filed on June 2, 2026, but the 10-Q remains pending. The company has 60 days to submit a compliance plan and up to 180 days to regain compliance. The notice has no immediate effect on listing, but the delay signals ongoing accounting complexity and heightened delisting risk for this micro-cap.

Key Financial Metrics

Deal Value
$7.5M

Actionable Insight

Monitor the compliance plan submission deadline (June 22, 2026) and Nasdaq's response. If the plan is rejected, an appeal to a Hearings Panel would be the next catalyst. The pending 10-Q filing will be critical for assessing financial health and accounting resolution. Given the micro-cap size and historical negative drift, any further delays or adverse Nasdaq decisions could accelerate downside.

Key Facts

  • Received Nasdaq delinquency notice on May 27, 2026 for late 10-K (FY2025) and 10-Q (Q1 2026)
  • 10-K filed on June 2, 2026; 10-Q still pending
  • Delay attributed to complex accounting matters: tax provision, variable interest entities, derivative accounting
  • Company has 60 days from April 23, 2026 (by June 22, 2026) to submit a compliance plan
  • If plan accepted, up to 180 days from 10-K due date (until October 13, 2026) to regain compliance
  • Completed $7.5 million financing in January 2026 and acquired Family Beginnings clinic
  • Market cap ~$2M; prior reports on this ticker show negative average T+20 returns

Financial Impact

Delisting risk for a $2M market cap company; $7.5M financing completed in January 2026 provides some liquidity buffer

listing statuscompliance timeline

Risk Factors

  • Nasdaq may reject the compliance plan, triggering delisting proceedings
  • Pending 10-Q may reveal further accounting issues or financial deterioration
  • Micro-cap liquidity and low market cap (~$2M) amplify volatility on any news
  • Historical reports on this ticker show negative average T+20 returns, suggesting persistent negative sentiment

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
80% bullish (5 analysts)

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3305650
6 reports for IVF
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for IVF — sortable, filterable
Type Now
Jun 2, 2026
2d ago
Press Release
BEARISH ★ 6/10
awaiting T+1
Jun 2, 2026
3d ago
8-K
MIXED ★ 5/10
$1.52 $1.70▲ +11.84%▲ +12.54%$1.50 (−1.32%)
Jun 2, 2026
3d ago
8-K
BEARISH ★ 8/10
$1.52 $1.70▼ −11.84%▼ −12.54%$1.50 (+1.32%)
Jun 2, 2026
3d ago
Press Release
MIXED ★ 5/10
$1.52 $1.70▲ +11.84%▲ +12.54%$1.50 (−1.32%)
Mar 3, 2026
13w ago
Press Release
NEUTRAL ★ 4/10
$4.33 $4.44▲ +2.54%▲ +1.78%$1.50 (−65.32%)
Feb 24, 2026
14w ago
8-K
BULLISH ★ 8/10
$5.00 $4.97▼ −0.50%▼ −1.33%$1.50 (−69.97%)
Showing 6 of 6

US Market Status

Market Open — Closes in 4m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access